Stay updated on LY3454738 Clinical Trial in Atopic Dermatitis
Sign up to get notified when there's something new on the LY3454738 Clinical Trial in Atopic Dermatitis page.

Latest updates to the LY3454738 Clinical Trial in Atopic Dermatitis page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedAdded detailed Locations sections listing study sites across Alabama, Arkansas, California, Florida, Kentucky, Maryland, Michigan, New York, North Carolina, Ohio, Oklahoma, Texas, Washington, and Caguas, Puerto Rico. Updated revision to v3.3.3.SummaryDifference2%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. No study details or essential content appear to be affected.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page footer notice about government funding status was removed; no study data, eligibility criteria, or locations were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check69 days agoChange DetectedMinor formatting adjustments and updates to contact information are observed, while the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check97 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check104 days agoChange Detected- Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.SummaryDifference0.7%

Stay in the know with updates to LY3454738 Clinical Trial in Atopic Dermatitis
Enter your email address, and we'll notify you when there's something new on the LY3454738 Clinical Trial in Atopic Dermatitis page.